Nanoparticle technologies for liver targeting and their applications in liver diseases
Frontiers in Bioengineering and Biotechnology · 23.10.2025 · 13
DOI: 10.3389/fbioe.2025.1661872 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 23.10.2025. Verfasst von Mengjia Peng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, The General Hospital of Tibet Military Command, Lhasa, China. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Tibet Autonomous Region.
Abstract (Originalsprache)
Liver diseases represent a significant global health challenge, affecting millions of lives annually. The advent of nanoparticle (NP) technologies has introduced promising therapeutic strategies for addressing liver diseases. Given the liver’s pivotal role in detoxification and the inherent ability to interact with circulating NPs, it emerges as an ideal target for NP-mediated therapies. Upon systemic administration, NPs predominantly accumulate within the liver, where they are uptaken and internalized by hepatic macrophages, sinusoidal endothelial cells, and hepatocytes. This natural tropism of NPs toward the liver highlights their potential for targeted liver disease management. This review describes the physiological conditions of the hepatic sinusoids and elucidates the interactions between various hepatic cells and NPs. A thorough understanding of these physiological mechanisms is essential for optimizing liver-targeted NP delivery systems, thereby improving NP accumulation at pathological sites. The development of liver-targeted NPs technologies holds immense promise for both the diagnosis and treatment of liver diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency, The General Hospital of Tibet Military Command, Lhasa, China.
- Department of Gastroenterology, Laboratory of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China.
- State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Förderung
- National Natural Science Foundation of China
- Science and Technology Department of Tibet Autonomous Region
Zitieren
APA
Peng, M., Fang, F., & Wang, B. (2025). Nanoparticle technologies for liver targeting and their applications in liver diseases. Frontiers in Bioengineering and Biotechnology, 13. https://doi.org/10.3389/fbioe.2025.1661872
Vancouver
Peng M, Fang F, Wang B. Nanoparticle technologies for liver targeting and their applications in liver diseases. Frontiers in Bioengineering and Biotechnology. 2025;13. doi:10.3389/fbioe.2025.1661872
BibTeX
@article{Peng2025,
author = {Peng, Mengjia and Fang, Fei and Wang, Bowen},
title = {Nanoparticle technologies for liver targeting and their applications in liver diseases},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2025},
volume = {13},
doi = {10.3389/fbioe.2025.1661872}
}
EUVIMED